www.fdanews.com/articles/113802-merrion-deal-could-be-worth-58-million

Merrion Deal Could Be Worth $58 Million

January 16, 2009

Dublin-based Merrion Pharmaceuticals has signed a licensing agreement with healthcare company Novo Nordisk, which specialises in diabetes care.
RTE Business